Adero Partners’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $7.02K | Hold |
652
| – | – | ﹤0.01% | 259 |
|
|
2024
Q4 | $8.35K | Sell |
652
-391
| -37% | -$5.01K | ﹤0.01% | 262 |
|
|
2024
Q3 | $28.8K | Hold |
1,043
| – | – | ﹤0.01% | 239 |
|
|
2024
Q2 | $30.3K | Hold |
1,043
| – | – | ﹤0.01% | 218 |
|
|
2024
Q1 | $46.5K | Hold |
1,043
| – | – | ﹤0.01% | 203 |
|
|
2023
Q4 | $40.5K | Hold |
1,043
| – | – | ﹤0.01% | 191 |
|
|
2023
Q3 | $30.7K | Buy |
1,043
+391
| +60% | +$11.5K | ﹤0.01% | 180 |
|
|
2023
Q2 | $41.5K | Hold |
652
| – | – | ﹤0.01% | 164 |
|
|
2023
Q1 | $30.8K | Hold |
652
| – | – | ﹤0.01% | 161 |
|
|
2022
Q4 | $45.3K | Hold |
652
| – | – | 0.01% | 161 |
|
|
2022
Q3 | $84K | Buy |
+652
| New | +$84K | 0.01% | 153 |
|
|
2022
Q2 | – | Sell |
-12,676
| Closed | -$1.28M | – | 158 |
|
|
2022
Q1 | $1.28M | Sell |
12,676
-11,893
| -48% | -$1.2M | 0.19% | 57 |
|
|
2021
Q4 | $3.8M | Buy |
+24,569
| New | +$3.8M | 0.62% | 33 |
|